Posted on

Cbd oil and dmso for als

Best CBD Oil Dosage:Best CBD Oil Of 2022

If it was before, Qingniang would definitely complain that she was abandoned by her parents again, and abandoned by good times, but after so much experience, Qingniang who has traveled so much, after seeing the reluctant eyes of her parents, she confirmed The whole heart was relaxed.I did so much myself, not just to let my parents live a good life.Make my brother happy.Now that I have done it myself, do I have to set off and move forward for my past life and my sister in this life Qing Niang thought so, and she has been working so hard.

2.CBD oil extraction Best CBD Oil Dosage

It really surprised the Fu family.Fugui, who had never traveled far, actually took Jiang Jiang s four year old daughter to the capital, and he found the daughter in law back very smoothly.Of course, it would be even more outrageous when the Fu family passed it on.Why Because Fugui actually met the biggest hero of the Dajing Kingdom, Lord Yongning, not to mention that they had met and chatted together, and what was even more enviable was that Hou Yongning almost didn t recognize Qingniang as his goddaughter Of course, all this is for later.

Next time, who can guarantee that when he encounters danger, he will pass it safely next time.Obviously, Xiaoxiang s where to buy CBD oil in australia proposal is satisfied after everyone thinks about it.Even Best CBD Oil Dosage Susu agrees with Xiaoxiang s idea.Qing Niang, I think this is better, although I don t understand the 85 mg ml of CBD oil great things you have done, and what kind of glory and wealth, when elixir CBD peppermint oil oral spray dosage I was young, my brother always taught me how much power and wealth to enjoy.No matter how much responsibility and risk I take, my brother has always hoped that when I grow up, I can live a peaceful and happy ordinary life, he said, only a person who lives freely can be a truly happy person.

Thank goodness.Grandpa, does your family have a big best CBD oil for dogs petsmart house Dad and thc CBD oil Best CBD Oil Dosage I have never lived in a big house before The old man didn t answer the question that was supposed to be a test, but when Fugui raised his hand, he nodded on Qingniang s forehead.You little girl, how big is our house We CBD oil dosage for ms actually think our house CBD oil depression Best CBD Oil Dosage is small.No, I won t be able to take does CBD oil help with hangovers you out next time.Don t learn CBD oil for gout badly when you see two rich people.Okay, Qing The mother can only smile bitterly how to apply CBD oil to back pain in her heart, when will her father turn his head and talk again, what is this called Father, if you touch Qingniang s forehead again, Qingniang will look like father best way to give CBD oil to cat s.

I have to say that the eldest daughter in law of the Fu family is really good at cooking.To be diligent, the second daughter CBD oil and seizures research in law Qin Feng is neat, but to say that the taste of cooking can only be said by the old masters.It s just because Mrs.Fu spoils where to get CBD oil Best CBD Oil Dosage her on weekdays, most of the cooking work falls on Qin Feng.As for the third daughter in law, she is the one who enjoys the most.She has benefits of CBD oil in beagles a good mouth and can coax people.Qingniang looked at the four pots apothecarium CBD oil of vegetables on the table, braised tofu, pros and cons of CBD oil for sleep roasted potatoes, stewed dried beans with bacon, and vinegared cabbage.

3.full spectrum CBD oil tincture Best CBD Oil Dosage

No, it s the first month now, Qin Feng doesn t know about the rest of the Dajing Kingdom, but she is very clear about the customs of Yushugou, and she must have lived for so many years.The steamed buns in the twelfth lunar month global green CBD oil Best CBD Oil Dosage of the house, but Qin dmso CBD oil Feng doesn t care about these, who makes her really not.That s fine, anyway, you just need to take off the fur.We re not just selling money for this.What kind of variety is it, but as long as the skin can be peeled off in good condition, even if it is given Best CBD Oil Dosage:Best CBD Oil Of 2022 a little, it will be exchanged for some money.

He thought about it, and of course Qin Feng was also happy.Qing Niang saw that her family was also on the right track, so she felt relieved.On a warm day after the New Year, she carried how to make CBD oil Best CBD Oil Dosage a few pieces of her clothes on her back and set out on the road.Although before this, the family members had been fiercely opposed, especially Fugui, who even clamored for the family to advance and retreat together, how could a teenage girl go to the capital alone to find blood relatives.But you really want them to give up their happy life now, how to take CBD tincture with mct oil especially after Xiao Tianxiang was helped by Hengdizi to enter the school in Pingshun County, many things have quietly changed.

Yo, look at this mouth, it s really sweet, what s your name, how old are you this year.Miss Qianjin, who was obviously not even two years older, did pretend to be decent.Xiaoqingniang held back her laughter and answered honestly Sister, just call me Qingniang, I ll be four years old during Chinese New Year.Obviously, the young lady in front of her is a very special example, only the girl from a really big family does this.rule.There is no sound at all when pouring tea and water, and these two girls have been kneeling in the car since Qingniang came in to work for their master.

What are you doing, no one will come straight up and take off the clothes.Besides, Best CBD Oil Dosage:Best CBD Oil Of 2022 my mother didn t tell you that I ve already settled for someone else In fact, Qing Niang s brain is really hot, and some have lost the calmness of the past.In a hurry, he told Xiao Tao about the marriage between himself and Xiao Tao, so that when he saw the face of the Wang family s aunt who kept turning green and white for a while, he regretted that he 1600 mg CBD oil almost bit his tongue off.This is a notoriously long tongued woman, this is fatal, especially after rejecting clear choice CBD oil the stupid big man, one can imagine how vicious it would be if his mother said it Originally, Qingniang thought it was the third aunt who was angry, but who would have thought that Wang Xiaoqiang, who was standing on the side, started howling.

Oh, Qing Niang, you should speak louder in the future, don t be like your second aunt, we are not a lady, so you should take it easy, or you will Best CBD Oil Dosage olive oil infused with CBD suffer a loss when you go outside.Well, auntie, my second aunt is fine, don t scold After Qingniang finished speaking, everyone laughed.It is estimated that the time is almost the same.Qingniang and Erya will go to someone buy purest CBD oil canada Best CBD Oil Dosage:Best CBD Oil Of 2022 else s house to pay Best CBD Oil Dosage New Year s greetings, and the Li family sisters are also going out, so after a while, the group split up and started an exciting and happy New Year s trip Seventy four beaten more today I don t know that this time out, Qingniang did not just go smoothly, just turned the corner CBD hero oil where to buy and was in a hurry to reach the old house of Fujia, Qingniang suddenly felt the back of her head Suddenly there was a strong wind, and one side turned around, and saw a group of children not far away staring at their CBD oil 600mg emperor s favorite second married princess.

The shrill voice flickered brightly and dimly, as if someone had cut a finger and stabbed the mouth of a glass cup.Qing CBD hemp oil concentrate Niang was really displeased with this feeling.Yo yo yo, why are there three virtuous women in our rso CBD oil backyard sonoma valley health CBD oil today It s a pity that they were caught in the palm of my hand by Fairy Ruhua, tsk tsk tsk, I promise to make you want to die in less than half a stick of incense.Even when I see a boar, I want to climb up and be happy, hahaha, Obviously, the six big men were used to such a scene, and everyone s arm strength increased, and the three that were pinched were already The tearful girl couldn t help but cry out.

At first, she was a little embarrassed, and she only secretly looked outside, but with the clamor from all over the place, and then again In addition, the lively street scene can really attract Qingniang s full how long does CBD oil take to kick in attention.The little CBD oil cream for pain Best CBD Oil Dosage girl can t control it anymore, so she almost sticks her head out of the frame, especially when she sees Bingtanghulu, it is natural to reach out to the big one.In front of b pure CBD oil were to buy the prince Sima Mingche.Yinzi, hurry up, I want to eat candied haws Seeing the prince giggling, Sima Mingche felt that he was being taken advantage of.

That s the prince.It is related to the future of the Great Yasukuni.The leader of best CBD oil for disease prevention the Jinyiwei Ouai also knew that this matter was difficult.He had to respectfully greet Yong Ning Hou before he said aloud Xiaguan Zhang Liang, please ak bark CBD oil also invite Lord Hou and this girl to meet the emperor with Xiaguan.As for what happened, Zhang Liang didn t dare to be a little arrogant.In fact, he really didn t have the guts.There is no such identity.The matter of the Tianjia is not something that an ordinary Jin Yiwei can comment on.

It s a good thing for the young lady.With Qin Feng s approval, Qing Niang happily brought all the delicious food to the table, and the three members of the family ate their mouths full of oil.After the meal was finished, Qingniang returned to Qin Feng s side, looking at the little brother CBD oil best time to use who was having a good time bulbar als CBD oil and talking to Qin Feng in a low voice.Mother, you went to my aunt s house, did you Best CBD Oil Dosage:Best CBD Oil Of 2022 mention going to the town Qin Feng actually wanted to talk to Qingniang about this for a long time, and it must be only her daughter who can discuss in this family, although the little girl is still young It s worse, but with her daughter s applied basic science CBD oil intelligence, Qin big sky CBD oil Feng is still very relieved.

Qin Feng gritted his teeth and couldn Best CBD Oil Dosage t help but speak.Hearing this Qingniang was also stunned, she turned her phoenix eyes and stared at her mother carefully.Guess it was because she was stared at by Qingniang and felt a little guilty, Qin Feng smiled awkwardly, and then Best CBD Oil Dosage:Best CBD Oil Of 2022 rubbed her hands together and said Well, I thought that if you didn t have silver coins, I would give you some, of course, you did it outside.After working for several years, how does CBD oil help cats you should have accumulated a lot.

Hold me and go to the right.Sure enough, with Sima Mingqing s foot strength, the guards at the back still didn t catch up even though he stretched out his hand.It is estimated that the reason is not only because thc CBD oil Best CBD Oil Dosage of Sima Mingqing s good kung fu, but also because they know that he There is no escape from her.Turning to the right and then going back, Qingniang clearly retreated to the back of the group of people, and Qingniang once are CBD oils and hemp oil the same again guided him to twist to another hill.Qingniang was a hunter by nature.

As for Fugui, Qin Feng raised his eyes and couldn t stop his tears from falling.While he s still in jail, let s go, cleanly.What is still unclear, although Fugui promised very well before he came, but he couldn t hold back his filial heart, especially with Fuzhen fanning the flames beside him.Qin Feng picked up Tianxiang and led Qingniang to straighten up slightly tremblingly before wanting to go out, but before amazon CBD oil for dogs reaching the door, an evil voice sounded bad cases when using CBD oil from behind.Second sister in law, Qingniang is your daughter, and our Fu family is Best CBD Oil Dosage not unreasonable.

This is also a small way for the little brother to stay together.Delicious, it means delicious and delicious.Moreover, the two of them have a secret place, and it must be open to play and no one will care.Go to your ruined CBD oil cream for pain Best CBD Oil Dosage yard.Come on, I won t go.A few years ago, I thought you buy CBD oil in columbus were enlightened.How about taking CBD oil could I know that you won t take good care of the stunning beauty I finally bought for you, cut, I won t go, I will Go find your father, and ask your father to assign you a crown prince, then I ll see best CBD oil syringe how crazy CBD oil price per gram you are Although he said this, he couldn t hold back Sima Mingqing s thick skin.

Or in this year, if Qingniang There is news, please also ask the third aunt to keep this stone house for Qingshan.To say that this request is a bit too much, but Qingniang alcohol and CBD oil is really reluctant.The old lady didn t know what Qing Niang was thinking, Don t worry.Our family has no shortage of money, let can you take CBD oil and drink alcohol s talk CBD oil for cats peeing in the house about it.The game you hunted for the piebald python and the big roe buy whole plant CBD oil uk deer is enough to build two houses like this, auntie.Keep it for you, and this house will be your home at any time.

In the butterbur liquid vs CBD oil middle of the night, there was still no movement.Finally, the three year old 30mg CBD oil Qingniang patted Qin Feng.Under the circumstances, he fell asleep in a daze.It can be said that Qingniang woke up later than yesterday, but why didn t Mrs.Fu get angry like yesterday, Qingniang suddenly discovered something bigger.Where s my cheap auntie 3rd party tested CBD oil for seizures in teens Chapter 7 Premature Birth When Qing Niang woke up from her slumber, she wandered around the entire yard of Fu s house and couldn t find her own.

Although Fugui is very filial, what he has cibdol CBD oil seen and heard in the prison for the past three years has made him firmer, otherwise, in the past three years, Fugui would not have been in trouble in the prison.If you don t say that this girl doesn t understand the rules, it s really not like the people of our old Fu family.Second brother, you can t hesitate any more.As long as you nod your head, I, Fuzhen, will promise you that I will marry you a beautiful Huanghuada.Girl, let s talk about it, Tianxiang is our Laofu s family, so we can best CBD oil reddit review t let these two outsiders take them away.

He lives for a long time, so his xinxing is correspondingly cunning and vicious.And its skin will also protect its body like a piece of armor.Hit a snake and hit seven inches, but to be honest, if you are not a professional snake Best CBD Oil Dosage:Best CBD Oil Of 2022 hitman, if you want to hit the seven inches of the snake s body, it will be even more difficult.Especially the monsters who are about to become spirits after so many years.To be precise is actually full spectrum CBD oil vape to be smarter.The piebald python was moving fast, and Qing Niang followed closely behind and was ready to attack.

Qingniang hurriedly squatted down and picked up the chestnuts 9 CBD oil buy one by one, Ying er saw this scene, and she felt pain in her heart, Oh, this is the 1000mg pure CBD isolate pure hempseed oil glutenfree vegan case for the child who is clearly held in her hands.Look at Erya CBD oil who is not much stronger than Qingniang, with dirt marks all over her body, chestnuts that have been 30 kg CBD oil bottle trampled a lot under her legs, a piece of stone and broken clods, where Ying er can guess.not bystolic and CBD oil reach.What is accidentally dropped, obviously being bullied, why is this child so active CBD oil tincture stubborn When Erya saw Qingniang picking up chestnuts, she suddenly remembered and where to find CBD oil exclaimed, Ah, my chestnuts, those who have suffered thousands of knives, Before Erya could scold, Qingniang quickly interrupted, Erya, hurry up.

No, it s too much best CBD oil place to talk about.Just tell me how many fish you want to buy.The price will be fair and you will be satisfied.Jian Su It s not a fake, Qingniang said it outright after thinking about it.It s like this.My Best CBD Oil Dosage:Best CBD Oil Of 2022 family opened a food shop.It was in the middle of the street.My brother has also been by the side to pay attention to Qingniang s words and deeds.Seeing Susu started chatting with people again and again, when the elder brother s heart is really hurting, he is such a charming little girl, and because he is busy with the fish shop every day, he doesn t even have a close friend.

If the Fu family was close to the town, Qingniang might have thought of other ways.Looking for a big family or something, but at this hour, it is really rare to not bully the poor and the weak.Finally, when Qingniang saw the second brother who helped her that day, her eyes what is CBD hemp oil used for lit up and she shouted loudly at the second brother.In fact, the boy had already seen a child wandering outside his restaurant with a big basket on his back What does he do He must always keep an eye on the guests who come to the door, but after waiting for a while, no baby comes in.

Best CBD Oil Dosage CBD oil reddit, (what is CBD tincture oil for) [2022-05-27] Best CBD Oil Dosage CBD vs hemp oil Best CBD Oil Dosage.

No, Li Chang is really CBD oil for congestive heart failure in dogs a good man.Qing Niang was CBD oil vs capsules reddit also grateful from the bottom of her heart, and hurriedly bowed respectfully to the old couple.Okay.I m also looking at the value of this big piebald snake.You stay here for a few days, and I will arrange to find a homestead for you as soon as possible.The guy you called can also be worth a lot CBD oil concentrate of money., I will directly offset the money from this homestead with a part of the snake s body, as for the money for building the thatched cottage, you can owe me first, and you can pay it back when you have it.

Well, this guy never thought that if he didn t bring Qing Niang, the adults in the donkey cart would let him carry the basket.Let s go, this full spectrum vs broad spectrum CBD oil old man s thinking is simply divine.Now even Qingniang already knows that the old man is indeed a little abnormal in his thinking because of his old age, but fortunately the old grandfather is a kindhearted person, otherwise, it would be really difficult.Old Li headed towards the door in a hurry, and took big strides towards the donkey cart.

I didn t think that I would be lucky today, but I got a big guy, especially when I just saw that Grandpa Li is a kind hearted and good Best CBD Oil Dosage person, so,, I m thinking about it.Qingniang was also in the dark, not knowing how sure she was, she really liked this Zhuangzi, although it was the farthest from the main street in the center of the county, but no matter how long the street was The county town I had seen before was much smaller, so this Zhuangzi Qingniang wanted to stay wholeheartedly.

, holding the old man surnamed Liu sobbing.Even the most hard hearted person will be melted by Qing Niang s tears.of.When Fugui saw Qingniang like this in the back, he couldn t bear it.When did his daughter have such a good relationship with the old man, it best CBD oil for anxiety vaping was really unbearable to see her crying and not feeling angry.Old man, if you don t, Best CBD Oil Dosage:Best CBD Oil Of 2022 just stay, don t worry, we won t delay your earning money.When my daughter in law gets better, we will take your donkey cart to go home.Besides, I ll pay american pickers CBD oil for sale you back.

Of course, after Qingniang sweetly called the shopkeeper a best CBD oil softgels for pain few times, the old shopkeeper was happy and broad spectrum hemp CBD oil waived the three cents for the little girl s accommodation.It seems aggressive dogs and CBD oil that it is still the same.Smile a lot to be able to rebirth the strongest peasant full text read.This is the conclusion that Qing Niang finally came to, and no one does not like to see smiling faces.Therefore, the young lady in this life, especially when she grew up, developed a habit of smiling before she said anything.

Moreover, thanks to the help of the Li family, the Qingniang family got on a ride, but this time the tall horse was replaced by a sturdy bull, and the large and comfortable body became a plank covered with straw.But extract CBD olive oil even so, for the Qingniang family, it was considered very good.Without an ox cart, you have to walk on your feet, and you can t get home even with a cart.Chatting with the driver all the way, Qingniang was hugged by Qin Feng and wrapped cali CBD oil Best CBD Oil Dosage in a very warm cotton seed.When did the winter in the capital become so warm.

Qingniang believed that all this was worth the rebirth of the demon hunter.There is the last one, Qingniang is holding this more beautiful baby in her hand.This is for you, I hope you will wear it all the time, it will keep you safe from all poisons.Seeing Qingniang raising her hand to hold the gem to herself with difficulty, Best CBD Oil Dosage Sima Mingqing knew that her choice was the right one.You have put it away, my poison has been cured.If this gem has the effect beanfreaks CBD oil of detoxifying hundreds of poisons, then I have absorbed one.

But that s it, Duke Jing also 200 dollar CBD oil took a look and knew that Qing er was very handsome.Fortunately, Honglian finally confessed 30ml of CBD oil that this Qinger was a woman.Otherwise, if you don t say that your own flesh and blood best publicly traded CBD oil companies will be lonely for the rest of your life, even the conditions that the prince has just put forward must be carefully considered.It is true that the beauty is in trouble.This conclusion was only amazed when Jing Guogong went to the water pavilion to see Qingniang.Of course, CBD oil before or after workout if the Crown Prince hadn t come, Jing Guogong wouldn t just be clamoring in his heart.

See also  Cbd oil business for sale

Fugui can still go to work in the bioscience labs pure CBD oil town, and does CBD oil interfere with blood thinners best CBD oil dc because of his good craftsmanship and popularity, Fugui s salary has always been first class, but why is Dad ,why is that Qingniang can t think clearly, can CBD oil help joint pain Best CBD Oil Dosage and the same old lady Fu and Qin Feng can t think clearly But all of this happened, and what about the useless ones.Mother, then my father was arrested, what should we do Qingniang asked, not to mention Qin Feng, even the old lady Fu was stunned Your father has Best CBD Oil Dosage been arrested, what else can we do The two of CBD oil cream for pain Best CBD Oil Dosage them asked Xiang Qingniang in unison.

The most painful punishment was like 6mg CBD oil this.Seven points in and three points out.It is impossible to come Best CBD Oil Dosage:Best CBD Oil Of 2022 out.In fact, this is also because Qing Niang didn t understand Ru Hua.If she were to how to vape CBD oil Best CBD Oil Dosage know that this fat woman was such a cruel and vicious person, hmph, this stone is are there different potencies of CBD oil not just a slap in the face.But CBD oil little rock arks that s it, Aunt Ruhua s right foot is definitely abolished, her tendon is broken and her bones are broken.She can t think of running with great strides in this life.He limped into an even uglier pig, and soon everyone would know how things ended.

With a look of helplessness, he smiled again.Qing Niang hasn t seen whole leaf CBD oil Best CBD Oil Dosage a few house deeds since she was so old.Especially if she has entered the house twice.Uncle, you quickly take it out and let Qing Niang grow her full spectrum CBD oil from colorado eyes.I know you are a akavie CBD oil ghost, okay, let s It s all here, and the uncle can still lie to you.Don t worry, come in quickly, you can finish things, don t dawdle.Dizi, as a bag of Pingshun County, Best CBD Oil Dosage:Best CBD Oil Of 2022 can say that he has not experienced any major events, what kind of things.People have not seen.

That s all there is to it.That s best CBD oil for pains why, when Qingniang woke up, the room was already filled with people who were very close to her.What s even more unexpected is that, in addition to Sima Mingqing, Jing Guogong and Shu Yun, there are also Xiaoxiang, Susu, who have never met before.Yes, it s true, because those two pretty girls with peach like eyes were exactly them.Qing Niang, you are expired CBD oil so cruel.Wake up quickly Susu s broken thoughts did not change in the slightest with age.The others looked at themselves with tears in their CBD coconut oil pills Best CBD Oil Dosage eyes, only the CBD oil cream for pain Best CBD Oil Dosage warm and familiar voice that had always been heard softly rang in their ears.

Her thin blade, which was as fast as a willow leaf, had to be rushed in the future, and Qingniang only felt a numbness in her CBD oil for anxiety and panic attacks Best CBD Oil Dosage neck, and then Qingniang knew in an instant that she Best CBD Oil Dosage had been taken.This was really won, because when Qingniang woke up again, she only felt powerless, and the kung fu she had always been proud of disappeared.This is how Xiaoxiang feels, so unwilling and helpless, Xiaoxiang is really suffering.Although Qingniang was weak all over, the phoenix eyes were still slightly raised and CBD oil and stress can CBD oil cure cancer she tried her best to twist her head.

It is estimated that 1 ranked CBD oil Qing can CBD oil help kidney disease Best CBD Oil Dosage Niang was also impatient to wait, and the voice just lamented again.I m the one who Best CBD Oil Dosage:Best CBD Oil Of 2022 you just cried alive.Well, what kind of shocking cry did I cry just now Qingniang is crying for the first time in my life., a CBD face oil Best CBD Oil Dosage cry back to the soul.Moreover, this time Qingniang also confirmed that the source of Best CBD Oil Dosage the voice just now was the shallow hole where she and Sima Mingqing avoided last time.Hey, this is really a good place, it s the best choice for escape and refuge.

The autumn melon was not big and fat The fat ones are a bit long, and they don t need to be cooked, just wash them and take a bite, um, the lips and teeth are fragrant, and best CBD oil and arthritis the crunchy ones are simply the top 5 CBD oil best in the Best CBD Oil Dosage world.Forget it, let s wait until I have a chance to plant it in the future.Put the seeds of these two kinds CBD oil with thc vs without of melons in the soil first, and bury them best wuality CBD oil according to the pit dug by the roadside Qingniang.It doesn t need to be too deep.Besides, on the side that is close to the melon vine, you can t plant things that are too high, so as not to affect each other s growth, of course, but also affect the appearance.

However, after hearing his father s words again, he was still too selfish.Qingniang is her savior, and sister Shu Yun is also her eldest sister by blood.Besides, she suffered from benefits of CBD oil cream a strange disease after urinating.Obviously, she is only seventeen years old and only looks like a seven or eight year old child.What else do I have But unwilling.Even if it CBD oil for dogs petsmart Best CBD Oil Dosage is really not reconciled, it should be someone else.Red Lotus once again thanked Sister Qing er for her life saving grace.These days, Red Lotus has caused a lot of better to smoke CBD or oil reddit trouble for Sister Qing er.

Just when Fugui was annoyed, the younger brother walked in from the door cheerfully.When Qingniang saw his appearance, she knew that there best CBD oil for dog arthritis was a way to this matter.Sure enough, CBD oil store near me Best CBD Oil Dosage the duo heard the complacent voice of the young man.Oh, let me tell you, originally the nobles in the elegant room upstairs didn t pay attention Best CBD Oil Dosage to this matter, but with my little second brother s buying CBD oil online maine three inch tongue, after a lot of hard work, Finally, the nobles agreed to take you with them, The little guy s head was lowered so high, then he squinted at Qingniang with the bridge of his nose, and the teasing little Qingniang laughed non stop.

Military pet, The chief s ever changing hot wife.Oh.I didn t expect such a wild girl to have such a ac dc CBD oil Best CBD Oil Dosage hobby, huh.It bset CBD oil for sleep s not a good thing The two girls who followed behind were stunning.This was the first time they heard it since they followed their master.The master said so many words.Especially after they heard the words that Qingniang exclaimed, their whole body was tight and tight, the master s temper was not good, this little girl is really ignorant.I thought Qing Niang would have two reactions after hearing what she said.

Thinking of what my sister is hemp CBD oil legal in australia once said to me, I couldn t help feeling CBD oil safe during breastfeeding remorse.It s all her fault, if it wasn t for her repeated mentions, why would she have been gaffe again and again.The seeds of hatred have already been planted, and at this time, this deep seated hatred is like nourishment, prompting it to take root and sprout, waiting for the opportunity to get nourishment again.It can thrive and overflow all the time.I, sis, I m so scared Qingniang immediately hid behind Qingshan with a pitiful look on her face, her delicate snow white hands tightly grasping Qingshan s arm, how weak and weak she was.

When Qin Feng saw Qingniang s performance, her heart was really mixed.Looking at the warm picture of unusual harmony, if someone passed by, she would definitely think that Qingniang was that woman s child.Thinking that my daughter has been a little distant from me since yesterday, especially when I was just cold and like a stranger, and thinking that this is just like the scriptures anncannmed CBD rich oil after leaving me for more than half a year, I can t help but feel sad in my heart, and I can t bear the tears.

I m sorry, mother Fugui closed his eyes, wondering if it was carolina farms CBD oil Best CBD Oil Dosage because he was counts kustoms CBD oil too disappointed or sad, but now he really doesn t want to see his most beloved daughter in law, Qin Feng broad spectrum CBD oil vs phytocannabinoid rich hemp oil who used to be gentle and honest and could not even say a curse word If he hadn t been imprisoned this time, would those who have lived with him for the rest of their lives have to hide it from him for the rest of his life.You go In the end, Fugui said those three words with difficulty, and he still hated her No, How Many CBD Oil Should I Eat Best CBD Oil Dosage Fugui, you can t do this to me, I have no choice but to, I, Qin Feng, who was really speechless, suddenly remembered Tianxiang in his arms, Fugui, I have given birth to a son for you.

Hello little sister, big box retail storesand CBD oil I want to ask CBD oil london how the grass carp and carp are sold in your store.If you buy more, will someone send them home.The little girl thought for a Best CBD Oil Dosage while, but instead of answering Qingniang s question, she smiled.He stood in front of Qingniang Best CBD Oil Dosage with a giggle, and only Best CBD Oil Dosage:Best CBD Oil Of 2022 then spoke after comparing.How do you know CBD oil for dogs buy that I m a little sister, maybe I m older than you, look I m a little taller than you, you want to call me Sister Susu.Uh, Qingniang looked up and saw that it was Susu The plain girl was indeed an marijuana CBD oil Best CBD Oil Dosage inch taller than herself, so she couldn t help feeling a little embarrassed.

Zhang, and the old family has given birth CBD oil cinnamon flavor to three sons Fu Qianying, Fu Qiangang, and Fu Qianbo, even the youngest son, Fu Qianbo.She is also six years older than Qingniang.The second child of the Fu family is Qingniang s father, Fugui.He is also one of the most outstanding men in the CBD oil for sale bulk Fu family, and he has a straightforward and honest temperament.Next wholesale CBD oil prices is Fu Zhen, the eldest girl of the Fu family.She is very successful.She has long been married to the eldest son of the Zheng family in the Buckwheat Valley of Lincun.

Your words count When did my words count The man like a rogue stretched out his hand to hold Qing Niang, and the little girl was only thirteen years old no matter what.Well, it would be better for you to support me for a few more years.I will only turn thirteen years old in May this year.If you are too young, you will suffer.In the end, Qing Niang, who couldn t hold back her face, lay down on her face.On the masked man.Disappointing I didn t expect this dead man to be so incomprehensible, seeing Qingniang crying reluctantly again, knowing that the game was almost done, so he sat up straight again.

Je m’inscris à la newsletter

Pour être informé.e de nos actions, actualités, publications et évènements.

J’accepte de recevoir votre Lettre d’informations et confirme avoir pris connaissance de notre charte de protection des données .

Cannabinoid Delivery Systems for Pain and Inflammation Treatment

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (


There is a growing body of evidence to suggest that cannabinoids are beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The transformation of cannabinoids from herbal preparations into highly regulated prescription drugs is therefore progressing rapidly. The development of such drugs requires well-controlled clinical trials to be carried out in order to objectively establish therapeutic efficacy, dose ranges and safety. The low oral bioavailability of cannabinoids has led to feasible methods of administration, such as the transdermal route, intranasal administration and transmucosal adsorption, being proposed. The highly lipophilic nature of cannabinoids means that they are seen as suitable candidates for advanced nanosized drug delivery systems, which can be applied via a range of routes. Nanotechnology-based drug delivery strategies have flourished in several therapeutic fields in recent years and numerous drugs have reached the market. This review explores the most recent developments, from preclinical to advanced clinical trials, in the cannabinoid delivery field, and focuses particularly on pain and inflammation treatment. Likely future directions are also considered and reported.

Keywords: cannabinoids, delivery system, pain treatment, inflammation, cannabidiol, Δ 9 -tetrahydrocannabinol

1. Introduction

Cannabis (Cannabis sativa) is a dioic plant that belongs to the Cannabaceae family (Magnoliopsida, Urticales). Knowledge of the medical and psychoactive properties of cannabis dates back to 4000 B.C. All of the different varieties of cannabis, including the one known as Cannabis indica, belong to the same species. All C. sativa plants produce active compounds, but each variety produces these compounds in different concentrations and proportions, which do not only depend on genomic background, but also on growing conditions and climate, meaning that they can be referred to as chemical varieties or chemovars, rather than strains [1]. Each chemovar contains varying concentrations of cannabinoids, a class of mono- to tetracyclic C21 (or C22) meroterpenoids. While more than 100 different cannabinoids can be isolated from C. sativa, the primary psychoactive compound is Δ 9 -tetrahydrocannabinol (THC), which was first isolated in its pure form by Gaoni and Mechoulam in 1964 [2]. Other pharmacologically important analogues are cannabidiol (CBD), cannabinol, cannabinoid acids, cannabigerol, and cannabivarins. In addition to cannabinoids, other components, such as the monoterpenoids myrcene, limonene, and pinene and the sesquiterpenoid β-caryophyllene, can also mediate the pharmacological effects of C. sativa [3].

Although phytocannabinoids have similar chemical structures, they can elicit different pharmacological actions. The identification of THC paved the way for the discovery, in 1988, of cannabinoid receptor type 1 (CB1) [4], and, later, of cannabinoid receptor type 2 (CB2) [5]. CB1 and CB2 belong to a family of seven transmembrane Guanosine Binding Protein-Coupled Receptors, are widely expressed and distinguished by their specific functions, localization and signalling mechanisms. They are one of the important endogenous lipid signalling pathways, named the ‘endocannabinoid system’, which consists of cannabinoid receptors, the endogenous ligands of cannabinoid receptors (endocannabinoids) and the enzymes that regulate the biosynthesis and inactivation of endocannabinoids. This lipid signalling system is involved in many important physiological functions in the central and peripheral nervous system and in the endocrine and immune systems [6,7].

The psychotropic effects of cannabis are principally mediated by CB1, which is widely distributed throughout the brain, but mainly in the frontal cortex, basal ganglia and cerebellum. CB1 is also present in several tissues and organs, including adipose tissue, the gastrointestinal tract, the spinal cord, the adrenal and thyroid glands, liver, reproductive organs and immune cells. The presence of CB1 receptors on chondrocytes and osteocytes, as well as evidence for their presence on fibroblast-like synoviocytes, makes CB1 particularly interesting in the study of rheumatic diseases [8]. CB1 activation inhibits adenylate cyclase and reduces cAMP levels and protein kinase A (PKA) activity, resulting in the activation of the A-type potassium channels and decreased cellular potassium levels [9].

CB2 is principally expressed in immune cells, but can also be found in various other cell types, including chondrocytes, osteocytes and fibroblasts, meaning that it can be considered the peripheral cannabinoid receptor. It is also present in some nervous tissues, such as dorsal root ganglia and microglial cells. CB2 shows 44% amino acid similarity with CB1, and similarly inhibits adenylate cyclase as well as activating mitogen-activated protein kinase. Moreover, CB2 activation can increase intracellular calcium levels via phospholipase C. While both CB1 and CB2 are coupled to G-proteins, the transduction pathways that they activate can be different, for example, in their interactions with ion channels [10]. The association of a particular variant of CB2, known as Q63R, with coeliac disease, immune thrombocytopenic purpura and juvenile idiopathic arthritis is particularly interesting for the field of autoimmune and rheumatic diseases [11].

Overall, seven different endogenous ligands have been identified as acting within the endocannabinoid system to date. The first two endocannabinoids are the derivatives of arachidonic acid N-arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol [12]. A third endocannabinoid, 2-arachidonoyl glyceryl ether (noladin ether) was discovered in 2001. N-arachidonoyl dopamine, O-arachidonoyl-ethanolamide (virodhamine), docosatetraenoylethanol-amide, lysophosphatidylinositol and oleoylethanolamide have since been described as ligands of endocannabinoid receptors [7].

The endocannabinoid system’s contribution to the regulation of such a variety of processes makes phytocannabinoid pharmacological modulation a promising therapeutic strategy for many medical fields, including the studies of analgesic, neuroprotective, anti-inflammatory and antibacterial activity [13,14].

THC is the primary psychoactive component of cannabis and works primarily as a partial agonist of CB1 (Ki = 53 nM) and CB2 (Ki = 40 nM) receptors [15] and has well-known effects on pain, appetite enhancement, digestion, emotions and processes that are mediated through the endocannabinoid system [7]. Adverse psychoactive events can be caused by THC, depending on dose and previous patient tolerance. By contrast CBD, which is the major non-psychoactive phytocannabinoid component of C. sativa, has little affinity for these receptors, (Ki for human CB1 and CB2 of 1.5 and 0.37 µM, respectively), and acts as a partial antagonist CB1 and as a weak inverse CB2 agonist (Ki as antagonist of CP55940 from 4.2 ± 2.4 to 0.75 ± 0.3 µM in different human cell lines) [16].

In a recent paper, experiments based on the functional effects of CBD on PLCβ3, ERK, arrestin2 recruitment and CB1 internalization, show a negative allosteric modulation of CB1 at concentration below 1 µM [17].

Additionally, other non-CB1 receptor mechanisms of CBD have been proposed, among them its agonism at serotonin 1A receptor (or 5-TH1A), vanilloid receptor 1 (TRPV1) and adenosine A2A receptors [18,19]. The complex physiological and pharmacological mechanisms and interaction of CBD with the endocannabinoid system and other molecular targets are extensively reviewed by McPartland et al. [20]. These data may help explain some of the observed CBD effects including analgesic, anti-inflammatory, anti-anxiety and anti-psychotic activity [21]. The combination of THC and CBD with other phytocannabinoids and other components, such as terpenoids and flavonoids, in cannabis may have a synergistic effect on pain treatment [22,23].

2. Role of Cannabinoids in Inflammation and Pain

Pain and inflammation are the body’s physiological responses to tissue injury, infection and genetic changes [24]. These responses can be divided into two phases: acute and chronic. The acute phase is the early, non-specific phase and is characterized by local vasodilatation, increased capillary permeability, the accumulation of fluid and blood proteins in the interstitial spaces, the migration of neutrophils out of the capillaries, and the release of inflammatory mediators (e.g., cytokines, lymphokines and histamine). Pain is produced by all these pro-inflammatory agents, that also lead to hyperalgesia through the activation of the corresponding receptors, which are expressed by nociceptive terminals ( Figure 1 ). If the condition that causes the damage is not resolved, the inflammatory process progresses towards subacute/chronic inflammation, which is characterized by immunopathological changes, such as the infiltration of inflammatory cells, the overexpression of pro-inflammatory genes, the dysregulation of cellular signalling and the loss of barrier function.

Simplified scheme representing the pathogenesis of pain following inflammatory disease or nociceptive stimulus, the cytokines involved in the process, the descending supraspinal modulation and the relive neurotransmitters and endocannabinoid retrograde signalling mediated synaptic transmission. Endocannabinoids are produced from postsynaptic terminals upon neuronal activation. Natural and synthetic cannabinoids act like the two major endocannabinoids shown in the scheme: 2-arachidonolglycerol (2-AG) and anandamide (AEA). Endocannabinoids readily cross the membrane and travel in a retrograde fashion to activate CB1 located in the presynaptic terminals. Activated CB1 will then inhibit neurotransmitter (NT) release through the suppression of calcium influx. NT can bind to ionotropic (iR) or metabotropic (mR) receptors. 2-AG is also able to activate CB1 located in astrocytes. Although endocannabinoid retrograde signalling is mainly mediated by 2-AG, AEA can activate presynaptic CB1 as well. Fatty acid amide hydrolase (FAAH) found in postsynaptic terminals is responsible for degrading AEA to AA and ethanolamine (Et). Inflammation lead to release of biochemical mediators (bradykinin (BK), serotonin (5-HT), prostaglandins (PG) etc.) and the up-regulation of pain mediator nerve growth factor (NGF). The substance P (SP) and calcitonin gene-related peptide (CGRP) vasoactive neuropeptides, released from sensory nerve, have also role in inflammation. The interaction with opioids, THC and nonsteroidal anti-inflammatory drugs are also represented.

Chronic state of inflammation plays an important role in the onset of classic inflammatory diseases (e.g., arthritis) but also of various diseases, including cardiovascular and neurodegenerative diseases, diabetes, cancer, asthma. The suppression or inhibition of inflammatory/pro-inflammatory mediators using synthetic anti-inflammatory compounds (both steroidal and non-steroidal) is one of the major routes for the treatment of inflammatory disorders. However, several common side effects, including gastric irritation and ulceration, renal and hepatic failure, haemolytic anaemia, asthma exacerbation, skin rashes, are often associated with the use of synthetic anti-inflammatory drugs [25]. Increasing amounts of evidence demonstrate that the endocannabinoid system actively participates in the pathophysiology of osteoarthritis-associated joint pain. Production and release of endocannabinoids are mediated, during inflammatory-joint disease, by the generation of pro inflammatory cytokines (interferon [IFN]-c, interleukin (IL-12, IL-15, IL-17, IL-18), chemokines, chemical mediators, such as nitric oxide synthetase (NOS)-2, cyclooxygenase-2 (COX-2), matrix metalloproteinases (MMPs) and various other arachidonic acid metabolic by-products [7]. Overall, preclinical and clinical data support the potentially effective anti-inflammatory properties of endocannabinoid agonists that target CB2 receptors.

The chronic pathological pain state, including neuropathic pain, is a leading health problem worldwide as it endures beyond the resolution of the pain source and can deeply impact quality of life [26]. Unlike physiological pain, in which tissue injury and/or inflammation can induce reversible adaptive changes in the sensory nervous system leading to protective sensitization, changes in sensitivity become persistent or chronic in neuropathic pain. Furthermore, the nervous system, peripheral or central, is injured in neuropathic pain. It is characterised by pain in the absence of a noxious stimulus and may be spontaneous in its temporal characteristics or be evoked by sensory stimuli (hyperalgesia and dynamic mechanical allodynia). For example, neuropathy is still among the most common diabetes complications, affecting up to 50% of patients, despite recent advances in treatment. There is no effective treatment with which to prevent or reverse neuropathic pain [27], thus current treatment is only directed at reducing symptoms. The treatment of chronic pain is still an unmet clinical need, where adequate pain relief is obtained using drugs with adverse effects on central nervous system side [28]. The quality of life of neuropathic pain patients is often aggravated by comorbidities such as sleep disorders, depression and anxiety compromise.

See also  Cbd oil pill for pain for sale

The finding of the endocannabinoid-mediated retrograde synaptic signalling pathway has opened up a new era, for cannabinoid research, including evaluations of their therapeutic use [29]. Selective CB2 agonists have shown considerable efficiency in a variety of neuropathic pain preclinical models, while increasing amounts of evidence, derived from clinical studies, have confirmed the potential of the cannabinoid system in affording benefits for patients with chronic pain and chronic inflammatory diseases (arthritis). Currently, patients with chronic arthritic and musculoskeletal pain are the most prevalent users of therapeutic cannabis products [30].

Preclinical studies have shown that cannabinoid receptor agonists block pain in various acute and chronic pain models and that inflammation is attenuated [31,32,33]. Both CB1 and CB2 receptor agonists demonstrate anti-nociceptive activity, whether used singly or in combination, with CB2 activity believed to affect microglial cells and thereby reduce neuro-inflammatory mechanisms [34,35]. The CB2 receptor is thought to be particularly important in central neuronal pain circuits, as agonist activity induces dopamine release in mid-brain areas, contributing to descending pain control and the placebo effect [36]. Inflammatory effects can either be modulated via the upregulation of cannabinoid receptor activity or increased production of endocannabinoids, providing an attenuation in joint destruction in preclinical models of inflammatory arthritis that mimic human rheumatoid arthritis [30,32]. Similarly, CB1 and CB2 receptor proteins and endocannabinoids are found in the human synovial tissue of patients with both rheumatoid arthritis and osteoarthritis [37].

Data from clinical trials on synthetic and plant-derived cannabis-based medicines have suggested that they are a promising approach for the management of chronic neuropathic pain of different origins [38,39,40]. It is also hypothesised that cannabis reduces the alterations in cognitive and autonomic processing that are present in chronic pain states [41]. The frontal-limbic distribution of CB receptors in the brain suggests that cannabis may preferentially target the affective qualities of pain [42]. Furthermore, cannabis may improve neuropathic pain reducing the low-grade inflammation consistent in the pathology [43]. Considering as a whole the problems of chronic neuropathic pain syndromes, which has a poorly understood pathogenesis, a complexity of symptoms and the lack of an optimal treatment, the potential of a therapeutic strategy centered on cannabinoid system appears really quite attractive. However, a range of adverse events (particularly somnolence or sedation, confusion, psychosis) may limit the clinical applications of therapeutics based on cannabis. Some current clinical guidelines and systematic reviews consider cannabis-based medicines as third- or fourth-line therapies for chronic neuropathic pain syndromes, for use when established therapies (e.g., anticonvulsants, antidepressants) have failed [44,45].

Beyond its effects on the inflammatory pathway, the endocannabinoid system also plays a fundamental role in neuronal development affecting axon and dendrite growth [46] and preclinical models have demonstrated that cannabinoid administration alters brain maturation in young animals and leads to neuropsychiatric consequences in adults [47]. Moreover, endocannabinoid system has also been accepted to play a significant role in the maintenance of gut homeostasis, and this is therefore, of particular interest in the management of inflammatory bowel diseases (i.e., Crohn’s disease and ulcerative colitis) that show increasing prevalence in Westernised countries [48].

3. Current Drug Dosage Forms and Novel Delivery Systems

A modern pharmaceutical approach to administration may start from the use of the cannabis plant for medical use, and then move on to the development of quality controlled extracts, the complete evaluation of their analytical profiles, and studies to assess the delivery of the correct dosage for optimal therapeutic effect. Cannabinoids are highly lipophilic molecules (log P 6–7) with very low aqueous solubility (2–10 μg/mL) [49], that are susceptible to degradation, especially in solution, via the action of light and temperature as well as via auto-oxidation [50,51]. Formulation can thus play a crucial role in increasing the solubility and physicochemical stability of the drugs. Commonly used strategies in marketed products include salt formation (i.e., pH adjustment), cosolvency (e.g., ethanol, propylene glycol, PEG400 etc.), micellization (e.g., polysorbate 80, cremophor ELP etc.), (nano)-(micro)-emulsification, complexation (e.g., cyclodextrins), and encapsulation in lipid-based formulations (e.g., liposomes) and nanoparticles [52,53,54,55].

Various administration and delivery forms have been tested for therapeutic use. Cannabis products are commonly either inhaled by smoking/vaporization, or taken orally. The oromucosal, topical-transdermal and rectal routes are minor, but interesting, administration routes. The pharmacokinetics and dynamics of cannabinoids vary as a function of the route of administration with absorption showing the most variability of the principal pharmacokinetic steps. Absorption is affected both by intrinsic product lipophilicity and by inherent organ tissue differences (i.e., alveolar, dermal vs. gastric). A variety of factors, such as recent eating (for oral), depth of inhalation, how long breath is held for and vaporizer temperature (for inhalation) all affect cannabinoid absorption, which can vary from 20–30% for oral administration and up to 10–60% for inhalation. A reference review detailing the pharmacokinetic and pharmacodynamic aspects of cannabinoids has been written by Grotenhermen [49]. The following sections explore the principal administration routes for cannabinoids, available products and the principal strategies (extracted from scientific literature and patents) that can be applied to improve cannabinoid efficacy and stability. Treatment indications and their level of evidence are also reported while the principal characteristics of the formulations have been summarized in Table 1 .

Table 1

Currently available dosage forms for cannabinoids and their innovative delivery systems.

Administration Route Name Drug Delivery System/
Dosage Form
Disease Application Development Stage References
Oral Dronabinol THC Solid HIV, chemotherapy Anorexia, nausea Market [56]
Oral Nabilone THC analogue Solid Chemotherapy, chronic pain Nausea, pain Market [59,60]
Oral Epidiolex CBD Liquid Lennox-Gastaud and Dravet syndromes Epilepsy Market [62,63,64]
Oral CBD Solid Crohn’s disease, GVHD Clinical trials [66]
Oral THC SEDDS Improving dissolution, stability Preclinical [69,70,71]
Oral THC-glycosides Prodrugs Drug-resistant inflammatory bowel disease Inflammation Clinical trials [72,73]
Oromucosal Nabiximols THC CBD 1:1 Spray Multiple sclerosis Spasticity Market [75,78]
Oromucosal Cancer Pain Clinical trials [77]
Oromucosal CBD Powder Formulation study [79]
Oromucosal THC CBD 1:1 Chewing-gum Several potential diseases Pain, spasticity, dementia etc. Preclinical [80]
Intranasal CBD Liquid formulations Bioavailability study Preclinical [82]
Pulmonary CBD Solid/liquid Formulation study [86]
Pulmonary Powder metered-dose inhaler Bioavailability study Clinical trials [87]
Transdermal Phytocannabinoids Induced dermatitis Inflammation Preclinical [92]
Transdermal CBD Gel Arthritis Inflammation Preclinical [93]
Transdermal CBD Ethosomes Oedema Inflammation Preclinical [95]
Transdermal CBD Gel Epilepsy, osteoarthritis, fragile-X syndrome Clinical trials [96,97,98]
Transdermal CBD Oil, spray, cream Epidermiolysis bullosa Pain, blistering Clinical treatment [100]
Transdermal CBD Patch Formulation study [112]
Transdermal CBD + hyaluronic acid Gel Pain, wound management Formulation study [105]
Transdermal CBD+ argan oil Rheumatic diseases Inflammation Formulation study [107]
Transdermal CBD+boswellic acid Inflammation Formulation study [108]
Topical ocular THC analogue Prodrugs Glaucoma Reduce intraocular pressure Formulation study [111]

THC, Δ 9 -tetrahydrocannabinol; CBD, cannabidiol; GVHD, graft-versus-host disease; SEDDS, Self-emulsifying drug delivery systems.

3.1. Oral Route

The primary advantages displayed by the oral administration of cannabinoids include the existence of pharmaceutical-grade compounds, standardized concentrations/doses and a non-complicated administration route. Oils and capsules currently allow for more convenient and accurate dosing than juices or teas from the raw plant. Nevertheless, absorption is slow, erratic and variable. Maximal plasma concentrations are usually achieved after 60–120 min, although this can take even longer (up to 6 h) and can be delayed. Furthermore, metabolism produces psychoactive metabolites. Extensive first-pass liver metabolism further reduces the oral bioavailability of THC, while effect duration varies from 8 to 20 h. Numerous (nearly 100) metabolites have been identified as being produced, primarily in the liver and, to a lesser degree, in other tissues, such as the heart and lungs [49].

There are three oral, and one oromucosal, cannabinoid pharmaceutical preparations that are currently available.

Dronabinol (Marinol ® from Abbvie Inc., Chicago, IL, USA) is a semi-synthetic form of THC, which is available in capsule form and as a solution, that has been approved by the FDA for appetite stimulation and the treatment of chemotherapy-induced nausea in patients with AIDS. Oh et al. have published a PK study that compares the oral solution and capsule forms of dronabinol under fasting and fed conditions. The solution formulation showed lower inter-individual absorption variability than the capsule formulation, especially in fed conditions, and this fact may be an important consideration in the selection of an appropriate dronabinol product for patients [56]. Dronabinol exerted a modest, but clinically relevant, analgesic effect on central pain in the pain treatment of patients with multiple sclerosis. Although the proportion of patients that showed adverse reactions was higher in dronabinol-treated than in placebo-treated patients, it decreased over the drug’s long-term use [57,58].

Nabilone (Cesamet TM from Bausch Health Co., Laval, QC, Canada) is a synthetic cannabinoid derivative that differs structurally from THC as its C-ring is saturated and contains a C-9 ketone group ( Figure 2 ). Nabilone is available, in a polyvinylpyrrolidone carrier, as a capsule (1 mg of drug). It displays antiemetic properties and is used for the control of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetics [59].

The structures of the principal cannabinoids described in the text.

Nabilone has higher bioavailability than dronabinol (95% vs. 10–20%) and presents a higher duration of action. Nabilone has recently proven itself to be a suitable and safe therapeutic option with which to aid in the treatment of cancer patients diagnosed with anorexia. An enriched enrolment, randomised withdrawal design trial (26 patients) assessed the efficacy of nabilone, in the treatment of diabetic peripheral neuropathic pain [60]. Nabilone has an interesting range of applications (e.g., quality of life in lung cancer patients) although larger trials are still necessary if more robust conclusions are to be drawn [61].

Epidiolex (from GW Pharmaceuticals plc, Cambridge, UK), is a liquid formulation of a CBD solution that has recently been approved in the US as an adjuvant treatment in Dravet syndrome, Lennox-Gastaut syndrome and severe myoclonic epilepsy in infancy. Results from double-blind, placebo controlled trials have recently been published [62,63,64].

Furthermore, other improved oral-dosage formulations and therapeutic applications have been presented in a number of patents. Clinical considerations of the oral administration of a solid-dosage, CBD-containing form for the treatment of inflammatory bowel disease have been published in a patent by Robson (GW patent) [65]. A small cohort of patients (8 patients) reported an improvement in Crohn’s disease. Furthermore, oral administration also led to another small cohort of patients being able to reduce steroid dose when treating inflammatory and autoimmune diseases [66]. Based on this research, a CBD therapeutic formulation is being developed by Kalytera Therapeutics (Novato, CA, USA) for the prevention and treatment of graft-versus-host disease. Kalytera initiated a randomised, open-label, dose-response and comparator-controlled phase IIb trial in December 2017 to evaluate the pharmacokinetic profile, safety and efficacy of multiple doses of CBD for the prevention of graft-versus-host-disease following allergenic haematopoietic cell transplantation ( > NCT02478424).

The manufacture, specifications, pharmaceutical tests and preliminary pharmacokinetics of CBD-containing, compressed tablets and granulates for peroral delivery have been reported in a patent by De Vries et al. [67].

Self-emulsifying drug delivery systems (SEDDS) can be significant in improving the dissolution, stability and bioavailability of THC and other cannabinoids. SEDDS, which are isotropic mixtures of oils, surfactants, solvents and co-solvents/surfactants, can be used in the design of formulations to improve the oral absorption of highly lipophilic drug compounds [68]. Murty et al. have described self-emulsifying drug delivery systems for per os administration in a number of patents, with the aim of improving the dissolution, stability and bioavailability of THC and other cannabinoids [69,70,71]. The solubility of the selected drug, in oils (soybean and sesame oils, oleic acid) and surfactants (Oleoyl polyoxyl-6 glycerides, medium-chain mono- and di-glycerides and propylene glycol esters, PEG hydrogenated castor oil) was assessed.

A CBD therapeutic formulation is being developed by Kalytera Therapeutics for the prevention and treatment of graft-versus-host disease. Kalytera initiated a randomised, open-label, dose-response and comparator-controlled phase IIb trial in December 2017 to evaluate the pharmacokinetic profile, safety and efficacy of multiple doses of CBD for the prevention of graft-versus-host-disease following allergenic haematopoietic cell transplantation ( > NCT02478424).

Vitality Biopharma (Los Angeles, CA, USA) have proposed an invention that has led to several cannabinoid glycoside prodrugs (cannabosides) being obtained and characterized [72,73] ( Figure 2 ). This method grants the gastro-intestinal targeting of THC, while avoiding narcotic effects. Vitality Biopharma have released data from independent clinical trial case studies which demonstrate that cannabinoids induced the remission of drug-resistant inflammatory bowel disease after eight weeks of treatment (Vitality Biopharma web site).

3.2. Administration through Mucosa

Drugs, such as cannabinoids, that are metabolized by liver and gut enzymes (first-pass hepatic metabolism), have specific pharmacokinetic requirements, demonstrate poor gastrointestinal permeability and cause irritation and therefore require alternatives to systemic oral delivery. Transdermal, nasal, inhaled-pulmonary and oral transmucosal delivery formulations enable drug uptake directly into the blood, thereby eliminating first-pass metabolism.

The development of the transmucosal dosage form has provided a non-invasive method of administration that has proven itself to be significantly superior to oral dosage in the relief of pain (e.g., oral morphine vs transmucosal fentanyl) [74].

Nabiximols (Sativex ® from GW Pharmaceuticals plc), is an oromucosal spray that contains a roughly 1:1 ratio of THC and CBD, as well as specific minor cannabinoids and other non-cannabinoid components (β-caryophyllene). It is administered at a dose that is equivalent to 2.7 mg THC and 2.5 mg CBD in each 100 μL ethanol spray. THC and CBD may reciprocally interact either by interfering with each other’s pharmacokinetics, or, at the cellular level, within the complex endocannabinoid signalling network. However, a study involving nine cannabis smokers reported that no significant pharmacokinetic differences were found in the similar oral THC and Sativex ® doses that were administered [75]. Furthermore, studies have suggested that the adverse effects of THC can be antagonized by CBD [76].

Nabiximols is used as an adjunctive treatment for the symptomatic relief of moderate to severe multiple sclerosis-caused spasticity in adults who have not responded adequately to other therapies, and who show clinically significant improvements in spasticity-related symptoms during an initial therapy trial. It may also be of benefit as an adjunctive analgesic treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis. This same preparation is also used as an adjunctive analgesic treatment in adult patients with advanced cancer who have moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain [77]. Although not superior to placebo in terms of the primary efficacy endpoint, nabiximols provided multiple secondary endpoint benefits, particularly in patients with advanced cancer who receive a lower opioid dose, such as individuals with early intolerance to opioid therapy.

Nabiximols has now received marketing authorization in EU countries for the treatment of spasticity and FDA investigational new drug (IND) status for the treatment of cancer pain. Some clinical trials into the use of Sativex for the treatment of neuropathic pain in multiple sclerosis patients have been successful [78], leading to the drug gaining approval in Israel and Canada. However, further work is still required to define the best responder profile for nabiximols and to explore its full potential in this field is still required.

Transmucosal formulations of CBD with Poloxamer 407, carboxymethyl cellulose and starch have been reported by Temtsin-Krayz et al. Nanoscale-range powders have been produced using the spray drier technique. Crossover bioavailability comparisons of this formulation and Sativex have also been reported [79].

A controlled-release chewing gum, made up of a (1:1) combination of CBD and THC, which provides oromucosal adsorption is being developed by Axim Biotech. Inc., (New York, NY, USA). The product is currently in clinical trials for the treatment of several diseases (pain, multiple sclerosis-associated spasticity, Parkinson’s disease, post-herpetic neuralgia, dementia etc.) [80]. More recently, Axim have also proposed chewing gums that are formulated to provide the controlled release of microencapsulated cannabinoids, opioid agonists and/or opioid antagonists during mastication [81].

The intranasal mode of administration (in which drugs are insufflated through the nose) has several advantages; the nasal cavity is covered by a thin mucosa that is well vascularised, meaning that a drug can be transferred quickly across the single epithelial cell layer directly into systemic blood circulation and avoid first-pass hepatic and intestinal metabolism, producing a fast effect. Bypassing the oral route may be more acceptable for patients who experience nausea, vomiting, oral mucositis and impaired gastrointestinal function. Furthermore, intranasal delivery is superior to iv injection because it is a non-invasive pain-free treatment that can improve patient compliance. The development of a nasal formulation of CBD could potentially aid in the treatment possible breakthrough pain and nausea attacks.

Paudel et al. have prepared a variety of formulations (CBD in PEG 400 alone and CBD in a 50:35:15 (v/v) PEG: saline:ethanol solvent system both with and without the following permeation enhancers: 1% sodium glycocholate or 1% dimethyl-beta-cyclodextrin) for the investigation of the intranasal permeation of CBD in an anesthetized rat nasal absorption model [82]. The intranasal application of CBD formulations resulted in the significant and relatively rapid absorption of CBD from the nasal cavity. The nasal absorption of CBD from all the formulations was rapid (Tmax ≤ 10 min), while the absolute CBD bioavailability achieved by the different nasal formulations was in the 34–46% range. Bioavailability decreased when the PEG content of the formulation was lowered from 100% to 50%, while the addition of permeation enhancers did not lead to AUC enhancements.

Bryson has described both semi-solid and liquid nasally administered cannabinoid compositions and a device to provide precise nasal administration [83]. A range of different formulations were described in the patent.

3.3. Pulmonary Administration

The intrapulmonary administration of cannabinoids is regarded as an effective mode of delivery as it results in the fast onset of action and high systemic bioavailability. Cannabis-related effects generally begin within a few minutes of the first inhalation (smoked or vaporized) and these effects can increase [84]. A peak value is reached after 10 min, and is maintained at a steady state for 3–5 h, which is in accordance with the plasma levels of THC [85]. Interestingly, the PK profile of inhaled cannabis is similar to that of intravenously administered THC, although it displays a lower AUC. The PK profile of CBD is very similar to that of THC, whether it is administered orally, intravenously or inhaled. These pharmacokinetics (rapid onset, short time peak effect and intermediate lasting effects) occur because first passage metabolism is avoided and are thus virtually impossible to replicate with the oral administration of cannabis or cannabinoids. The major limitation of inhaling is the variability in inter-patient efficiency that is caused by differences in inhalation techniques, respiratory tract irritation during inhalation, etc. In fact, improved methods with which to standardise dosage have been proposed for these very reasons.

A protocol to deliver CBD and THC via vaporisation has been described by Solowij et al. Crystalline-form CBD (preliminary experiments), and ethanolic solutions of CBD (4 or 200 mg) and THC (4 or 8 mg) were separately loaded onto a vaporiser filling chamber via a liquid pad (a removable disc made of tightly packed stainless steel wire mesh) as supplied by the manufacturer of the Volcano ® vaporizer device [86].

A system, which combines method, devices and systems, for the controlled pulmonary delivery of active agents has also been reported; a metered dose inhaler to vaporize precise amount of agent (cannabinoids or other plant oils), a system for the evaluation of the PK value obtained after one or two puffs and an interface for the control of the profile of the drug administered have been provided by Davidson et al. [87].

Several patents have presented systems for vaporisation and nebulisation, from a variety of containers [88], at a selected temperature to form a precise amount of vapour with THC and CBD [89]. Improved drug-delivery devices that can separate and release active cannabis substances have been disclosed in another patent [90]; drug delivery cartridges, which include a substrate coated with at least one of either THC or CBD, are configured to allow for the passage of air through the cartridge to volatilise the agent for inhalation by a user.

3.4. Topical and Transdermal Route

Transdermal administration delivers drugs through the skin via patches or other delivery systems. Although comparable to oral-dosage forms in term of efficacy, transdermal patches provide numerous advantages. Transdermal administration avoids the first-pass metabolism effect that is associated with the oral route and thus improves drug bioavailability. Furthermore, transdermal administration allows a steady infusion of a drug to be delivered over a prolonged period of time, while also minimising the adverse effects of higher drug peak concentrations, which can improve patient adherence. Topical administration is potentially ideal for localised symptoms, such as those found in dermatological conditions and arthritis but also in peripheral neuropathic pain for which capsaicin patches have been proposed as a second line treatment after high quality of evidence was provided [91]. However, there are some disadvantages to consider, such as the possibility of local irritation and the low skin penetration of drugs with a hydrophilic structure. Indeed, drugs that are slightly lipophilic (log P 1–4), have a molecular mass of less than 500 Da and that show efficacy at low dosage (less than 10 mg/day for transdermal administration) are ideal for administration via this route. Enhancers may also be also added to transdermal formulations to increase the penetration of permeants by disrupting the structure of the skin’s outer layer, i.e., the stratum corneum, and increasing penetrant solubility.

The evaluation stages for the transdermal administration of cannabinoids range from early preclinical phases and mouse models, to self-initiated topical use and randomized, double-blind controlled studies.

The topical anti-inflammatory activity of phytocannabinoids in a roton oil mouse ear dermatitis assay has been described by Tubaro et al. [92], while preclinical evaluations of the transdermal administration of CBD, via gel application, has been further tested on a rat complete Freund’s adjuvant-induced monoarthritic knee joint model [93]. In this latter study, CBD was found to demonstrate therapeutic potential for the relief of arthritic pain-related behaviour and to exert an anti-inflammation effect without any evident high-brain-center psychoactive effects. Results showed that a dose of 6.2 mg/day reduced knee-joint swelling and that increasing the dose to 62 mg/day failed to yield additional improvements. The transdermal administration of CBD has also been observed to provide better absorption than the oral administration route in same arthritic model [30].

Ethosomal carriers are mainly composed of phospholipids, (phosphatidylcholine, phosphatidylserine, phosphatidic acid), with a high concentration of ethanol and water [94]. An ethosomal formulation for CBD, which consisted of 3% CBD and ethanol in a carbomer gel, has been prepared by Lodzki et al. [95], and its anti-inflammatory effect was tested on carrageenan-induced aseptic paw oedema in a mouse model. The results demonstrated that the carrageenan-induced development of an oedema was only prevented in its entirety in the CBD-pretreated group of mice. The in vivo occluded application of CBD ethosomes to the abdominal skin of nude mice resulted in high accumulation of the drug in the skin and the underlying muscle.

A topical transdermal gel containing a proprietary and patent-protected CBD formulation is being developed by Zynerba Pharmaceuticals (Devon, PA, USA) and is currently in clinical development for the treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome and osteoarthritis [96,97,98]. The gel is designed to be applied once or twice daily. Permeation profiles of a range of formulations have also been reported [99].

See also  Best cbd oil for sjogrens

A particularly interesting, although anecdotal, result has recently been published by Chelliah et al., who described the benefits that CBD provided as anti-inflammatory agent in three patients affected by epidermiolysis bullosa. Paediatric patients benefited from the use of topical CBD (applied as an oil, cream and spray by their parents) leading to a reduction in pain and blistering as well as rapid wound healing [100]. There were no adverse effects reported, either by the patients or their families, of this topical use of CBD.

The release of cannabinoids from a microneedle formulation that is administered transdermally has been reported by Brooke [101], while a patent by Weimann has more recently focused on CBD delivery [102]. In this latter work, a solution of CBD 10% in ethanol with modified cellulose gave a thixotropic preparation that was placed in a reservoir. Diffusion through the skin occurs and is measured using hydrophilic and hydrophobic membranes. A monolithic version, also containing penetration enhancers (oleic acid and propylene glycol), was also prepared for comparison purposes. Linear release was observed for 24 h and cumulative amounts exceeded 200 µg/cm 2 .

A range of patents for the topical administration of CBD, mixed with other well-known anti-inflammatory phyto-derived products, will also be summarised here, as will their adsorption and effect on pain relief.

Siukus has presented an oleo gel composition made up of non-psychoactive Cannabis sativa components for the treatment and/or reduction of deep tissue joint and muscle inflammation caused by mechanical skeletal muscle trauma and arthritis/osteoarthritis. The oleo gel composition is based on phytocannabinoids (2% of total mass) mixed with an extract of Olea europaea (Olive) (82%), Mentha arvensis leaf oil (0.5%), and anhydrous colloidal silica (8.2%) [103]. Preclinical evidence was reported.

The same author has more recently published a patent that describes a topical composition made up of an essential combination of synergistically acting phytoactive materials and non-psychotropic phytocannabinoids in combination with a Calendula flower extract (Calendula officinalis L.) and the base formulation to provide anti-inflammation, anti-oxidation, emollient and bactericidal activity [104].

Jackson et al. [105] have proposed a topical administration of CBD with silicon fluids, coupled with hyaluronic acid. This system is claimed to enhance application methods and improve absorption into the skin to help ease pain.

The use of cannabinoids, in combination with odorous volatile compounds and emu oil has also been proposed as a method to improve the effectiveness of cannabinoid transdermal delivery to areas in the hypodermis [106].

The application of CBD with argan oil for the treatment of the pain and swelling associated with inflammation, in arthritic and rheumatic diseases, has been described by Shemanky et al. [107]. Gel, cream and emulsion formulations were tested.

Improved anti-inflammatory effects can be obtained from a composition containing boswellic acids, either isolated from Boswellia family plants (Buseraceae) or in the form of an extract, and either CBD or a Cannabis sativa extract [108].

In order to complete this overview of topical CBD, we should note that CBD exerts interesting sebostatic and anti-inflammatory effects on human sebocytes [109], (data obtained from in vitro evaluations). Indeed, CBD has been shown to inhibit the proliferation of hyperproliferative keratinocytes [54], and to possess remarkable antibacterial activity [55]. The authors also demonstrated the potent local activity of CBD as an anti-acne agent. Furthermore, its high lipophilicity means that CBD is expected to preferentially enter the skin via the transfollicular route and to accumulate in the sebaceous gland.

Finally, the topical (ocular) administration of THC prodrugs has been proposed as a treatment to reduce intraocular pressure in glaucoma [110]. THC appears to be especially attractive in this case as, in addition to its intra ocular lowering activity, the presence of cannabinoid receptors in ocular tissues has recently been confirmed [111]. Hydrophilic THC prodrugs have been obtained by linkage with valine, with dipeptides and amino acid-dicarboxylic esters ( Figure 2 ). Among them the best corneal permeability and intraocular pressure-lowering activity shown by these prodrugs were observed in the THC-Val-HS emulsion and micellar solution formulations.

3.5. Nano-Technological Approaches

Pharmaceutical nanotechnology is widely used in drug delivery as it can develop devices that are specifically adapted to improving the therapeutic efficacy of bioactive molecules. Indeed, nanocarriers, such as nanoemulsions, dendrimers, micelles, liposomes, solid lipid nanoparticles and nanoparticles of biodegradable polymers for controlled, sustained and targeted drug delivery, are popular and present possible alternatives to traditional formulation approaches. Nanovectors for drug delivery potentially offer a number of advantages: more efficient delivery of highly lipophilic drugs at high doses, protection from aggressive environments (e.g., acidic pH in the digestive tract), as well as targeted and controlled delivery to achieve precise administration to a specific tissue over a determined period of time (e.g., pegylation [113], coating with polysaccharides [114], etc.). Even though the use of nanocarriers as drug-delivery systems offers many advantages, there are still some drawbacks that need to be addressed: instability during blood circulation, low renal clearance, limited accumulation in specific tissues and low uptake by target cells. Physico-chemical aspects, such as surface charge, size, shape and deformability, modulate uptake and interactions with host cells as well as influencing uptake by immune cells, the subsequent immune responses and nanovector biodegradation [115]. An interesting work on the limitations, opportunities and concerns in this field has recently been published by Park [116]. Significant research effort has been dedicated to the development of nanocarriers for the treatment of cancer, neurological diseases, cardiovascular diseases and use as antimicrobial agents, for which the principal route is systemic administration.

Their high lipophilicity and low stability (degradation via the effects of temperature, light and auto-oxidation can occur) mean that cannabinoids benefit greatly from nanotechnology approaches [51]. Indeed, recent years have seen micellar, liposomal and nanosized formulations being proposed for use in topical and systemic preparations. A brief description of the approaches presented in patents and in the literature, follows, while principal formulation data are reported in Table 2 .

Table 2

Nanosized cannabinoid delivery systems.

Type Constituents Drug Size (nm) Encapsulation Efficiency Application Development Stage References
Lipid-based liposomes DPPC, cholesterol THC 300–500 0.3 mg/mL i.v. Pharmacokinetics [117]
micelles PC, PE plus phospholipids Terpenes, hemp oil n.d. Stability evaluations [118]
micelles Polyethoxylated castor oil, glycerol Cannabis oil 100 n.d. oromucosal Clinical trials [119,120]
NCL tristearin/tricaprylin 2:1 Cannabinoids 100 high Formulation study [122]
NCL Cetyl palmitate or glyceryl dibehenate THC 200 n.d. nasal Preclinical studies [123]
NCL Glyceryl dibehenate or glyceryl palmitostearate CB-13 120 99% oral Preclinical studies [125]
PNL PTL401 THC CBD 1:1 99% oral Preclinical studies [130]
PNL PTL401 Plus piperine 99% oral Clinical trials [131,132]
Nanoemulsions rectal/vaginal n.d. [133]
Polymeric-based PLGA plus coating agents CB-13 253–344 85% oral Preclinical studies [137]
PLGA plus coating agents THC 290–800 96% oral Preclinical studies [138]
PCL CBD 2000–5000 100% locoregional Preclinical studies [139]

NCL, nanostructured lipid carrier; PNL, pro-nano-liposphere; PLGA, poly(lactic-co-glycolic acid); PCL, Poly-ε-caprolactone; PC, phosphatidylcholine; PE, phosphatidylethanolamine; EE = encapsulation efficiency calculated as (total drug added-free non-entrapped drug) divided by the total drug added; PLT401 is a proprietary formulation containing polysorbate 20, sorbitan monooleate 80, polyoxyethylene hydrogenated castor oil 40, glyceryl tridecanoate, lecithin and ethyl lactate; n.d., not defined.

3.5.1. Lipid Carriers

Although liposomes are one of the most frequently studied and used market-approved drug delivery systems [55], only a few patents involving cannabinoids have been published. The main disadvantage for liposomes in the encapsulation of lipophilic compounds is their reduced ability to locate such compounds in their phospholipid bilayer. Low encapsulation efficiency, or drug loading (ratio of encapsulated drug/sum of all components), is normally obtained for this reason. Rapid bioavailability and onset in the pulmonary administration of loaded-THC liposomes has been reported by Hung [117]. The formulation was composed of dipalmitoylphosphatidylcholine and cholesterol, giving liposomes with an average size of 300–500 nm containing 0.3 mg/mL THC. Pharmacokinetic data described slow and prolonged release that continued for more than 5 h after administration.

Micellar and liposomal preparations have also been proposed by Winniki et al. [118]. Micelles of 1 μm diameter were obtained via solvent injection in water and rapid solvent removal, while liposomes were produced using phosphatidylcholine ~52%, phosphatidylethanolamine 20%, phospholipids 26% and other compounds in a 2% mixture, via film hydration and solvent injection, ultrasonication and calcium alginate encapsulated liposomal suspension. Stability ranged from a few days (micelles) to several months (liposomes).

A nano-technology platform proposed by Medlab Clinical (Sydney, NSW, Australia), named NanoCelle TM , that is made up of micelles obtained by mixing oils, glycerol and non-ionic surfactants is currently undergoing advanced trails. Micelles of nanometer size (less than 100 nm) and positive average Z potential have been observed to deliver lipophilic molecules (vitamin D3, statins, testosterone propionate, CBD) for absorption across the oral buccal mucosa, bypassing the gastrointestinal tract. Early research into their use in the treatment of pain is underway in Australia [119,120].

Lipid nanoparticles in a solid particle matrix are produced from oil/water emulsions by simply replacing the liquid lipid (oil) with a solid lipid, i.e., one that is solid at body temperature. First generation analogues, produced from a solid lipid only, are named solid lipid nanoparticles. The second generation of nanostructured lipid carrier (NLC) particles are produced from a blend of a solid lipid and a liquid lipid, in which the partially crystallized lipid particles, with mean radii ≤ 100 nm, are dispersed in an aqueous phase containing one or more emulsifiers [121]. NLC can be considered suitable carrier systems for THC and CBD because they make use of solid particle matrices instead of fluid matrices, such as emulsions and liposomes, meaning that NLC can better host substances and protect them from degradation. The solid particle matrix is also able to slow the diffusion of THC from inside the particle to the particle surface.

Esposito et al. have described the development of a method to encapsulate cannabinoid drugs (precisely the inverse agonist of the CB1 receptor (AM251 and Rimonabant) and the URB597 fatty acid amide hydrolase inhibitor) in NLC [122]. In this circumstance, the lipid phase was composed of tristearin/tricaprylin 2:1 while Poloxamer 188 was added to the water phase. Nanoparticles of around 100 nm with high encapsulation efficiency were obtained.

NLC have recently been proposed for administration as a dosage form for nasal delivery. Nanospheres of 200 nm diameter, composed of either cetyl palmitate or glyceryl dibehenate and loaded with THC were obtained. In vitro mucoadhesion evaluations have revealed that cationic NLC formulations (obtained via the addition of cetylpyridinium chloride) should have high mucoadhesiveness properties [123]. The solid matrix of the NLC was found to have a stabilizing effect on THC. Indeed, 91% of the THC was unaltered after 6 months storage at 4 °C. About 1.7 mg THC is administered with one spray of the 0.25% THC-loaded NLC formulation in each nostril. This amount was close to the THC amounts obtained from the oromucosal formulation in a study by Johnson et al. [124].

Lipid nanoparticle formulations have been also reported, by Duran-Lobato et al. [125], to incorporate and deliver CB-13, a cannabinoid drug that acts as a potent CB1/CB2 receptor agonist, and show therapeutic potential. Nanoparticles composed of either glyceryl dibehenate or glyceryl palmitostearate and stabilized with two different surfactants (polysorbate 20 and sodium deoxycholate), were produced using the emulsification-solvent evaporation method. The best formulation in terms of size (120 nm) and polydispersity was obtained using glyceryl palmitostearate as the lipid matrix, which was effective, in the presence of lecithin, in the preparation of cannabinoid-loaded particles with high EE (around 99%) and stability upon storage at 4 °C. In vitro biocompatibility was assessed and demonstrated that that this type of formulation is safe. Furthermore, neither free CB-13 nor LNP produced cytotoxic effects in three cell lines at the tested dose (250 μg/mL of each LNP formulation for 24 h). This formulation was also stable under intestinal conditions, seemingly making it suitable for the oral delivery of CB-13.

Formulations that are based on self-(nano)emulsifying drug delivery technology (SEDDS) have been proposed as a means of improving the oral bioavailability of drugs that show poor aqueous solubility [126]. The base formulation, which is an isotropic mixture of an active compound in combination with lipids, surfactants and a co-solvent, has been called a pro-nano-liposphere (PNL) pre-concentrate and is ingested as a soft gelatine capsule. When it reaches the aqueous phase of the gastrointestinal tract, the PNL spontaneously forms a drug-encapsulated oil/water micro-emulsion with a particle diameter of less than 60 nm. The clinical usefulness of SEDDS, which stems from their ability to increase the solubility and oral bioavailability of poorly soluble drugs, have led to them attracting considerable interest [127]. Products, such as Sandimmune ® Neoral (cyclosporin A), Fortovase ® (saquinavir) and Norvir ® (ritonavir), have confirmed the value of this approach [128]. PTL401 is the proprietary PNL-based formulation of THC and CBD. The PTL401 formulation is composed of THC-CBD (1:1) in a formulation with polysorbate 20, sorbitan monooleate 80, polyoxyethylene hydrogenated castor oil 40, glyceryl tridecanoate, lecithin and ethyl lactate [129,130]. The CBD-THC PNL formulation also allows absorption enhancers, such as curcumin, resveratrol and piperine, to be incorporated. PK evaluations in a rat model have indicated that only piperine enhanced the oral bioavailability of CBD in-vivo [130]. Moreover, the enhanced oral bioavailability can be attributed to the inhibition of intestinal processes, rather than those of hepatic first-pass metabolism, while additional increases in the AUC of CBD prove that piperine-PNL also has an effect on phase II, and not on just phase I, metabolism. THC-CBD-piperine-PNL demonstrated higher absorption rates than Sativex ® in human volunteers, with peak values of 1 h for both THC and CBD, versus 3 h for THC and 2 h for CBD, respectively. Furthermore, the incidence and severity of reported adverse events were similar in both groups [131,132]. Nevertheless, regarding the role of piperine, it is important to remember that it is able to alter the metabolism of many drugs, being a cytochrome and glucuronyl transferase inhibitor. In addition, piperine demonstrates non-negligible toxicity (it is Generally Recognized as Safe only up to 10 mg/day).

Micro and nanoemulsions of active annabis ingredients (cannabinoids and terpenes) have also been presented in a patent [133], which proposes rectal-vaginalC and solid oral dosage forms.

A proprietary CBD nanotherapeutic formulation (CTX01) for subcutaneous administration is being developed by Cardiol Therapeutics (Oakville, ON, Canada) the treatment of heart failure with preserved ejection fraction. Preclinical studies are currently under way (Cardiol web site) [134].

3.5.2. Polymeric Carriers

Polymers have played an integral role in the advancement of drug delivery technology and this field has grown tremendously. Polymers are currently used in pharmaceutical formulations and show a wide range of safety and biodegradation variables. Developments in responsive polymers, polymer therapeutics and advanced systems for molecular recognition or for the intracellular delivery of novel therapeutics have more recently appeared [135,136]. Polymeric drug delivery systems are able to protect drugs from degradation and control drug release.

The poly (lactic-co-glycolic acid) (PLGA) polymer is one of the most commonly used materials for the encapsulation of drugs, as it is mechanically strong, hydrophobic, biocompatible and degrades into toxicologically acceptable products that are eliminated from the body.

PLGA nanoparticles, loaded with CB-13 for oral delivery, have been coated with a variety of agents (chitosan, Eudragit RS, vitamin E and lecithin) [137]. The nanoparticles exhibited particle sizes of 253–344 nm and high entrapment efficiency values (around 85%). Higher release rates were obtained with vitamin E and lecithin surface modification. Biodistribution evaluations revealed that none of the proposed surface modifications prevented the opsonisation process (liver and spleen uptake). Nonetheless, CB-13, which is highly lipophilic and displays low water solubility, can be absorbed well when it is included in these surface-modified polymeric carriers.

Biocompatible polymer PLGA was preferred by Martin-Banderas for the preparation of THC-loaded nanoparticles for use as an anticancer agent [138]. Nanoparticles, with sizes ranging from 290–800 nm, were obtained with PEG, chitosan and PEG-chitosan being used as coating agents. Encapsulation efficiency and drug loading (around 96% and 4.8%, respectively) were not affected by the type of coating used and sustained drug release, of up to 10 days, was obtained. Surface modification with PEG reduced protein adsorption and thus, most likely, the in vivo opsonisation processes.

Poly-ε-caprolactone (PCL) is another polymer that is widely used in drug delivery systems. This is a biocompatible, biodegradable, FDA-approved, semi-crystalline aliphatic polyester that degrades slowly. Hernán Pérez de la Ossa has developed a formulation in which CBD is loaded into PCL particles. Spherical microparticles, with a size range of 20–50 μm and high entrapment efficiency (around 100%), were obtained. CBD was slowly released over within ten days when dissolved in the polymeric matrix of the microspheres in an in vitro test [139].

4. Critical Overview of Clinical Studies

Contrasting the abundance of public domain comment on the therapeutic effects of cannabinoids is the fact that there has only been a limited number of rigorous clinical studies on the topic, due to the illegal status of cannabinoids in most countries. Nevertheless, the licensing of Cannabis-based medicines, including herbal Cannabis for people with chronic (neuropathic) pain, is scheduled to occur in some countries and has already happened in Canada, Germany and Israel. Heated debate as to the true efficacy and side effects of Cannabis products and derivatives is therefore on-going. In 2017, the Health and Medicine Division of the US National Academies concluded that there is substantial evidence to support the claim that cannabis is effective for the treatment of chronic pain (cannabis), especially neuropathic pain in adults, for use as antiemetics in the treatment of chemotherapy-induced nausea and vomiting (oral cannabinoids), and as a means to improve patient-reported multiple sclerosis spasticity symptoms (oral cannabinoids) [140]. Nevertheless, only in recent years have a significant number of systematic reviews and meta-analyses evaluated the effects of all cannabinoids in all diseases and focused on cannabinoid use for chronic pain. Whiting et al. selected 79 trials and concluded that there was moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity, while there was low-quality evidence for improvements in nausea and vomiting due to chemotherapy, weight gain in HIV, sleep disorders, and Tourette syndrome. Cannabinoids were also associated with an increased risk of short-term side effects [141]. Nugent et al. selected 29 chronic pain trials and suggested that there is some, limited evidence to indicate that cannabis is able to alleviate neuropathic pain in some patients, but also that insufficient evidence exists in other types of chronic pain [142]. Furthermore, Mücke et al. have also declined to share in the optimistic conclusions that cannabis-based medicines are effective, well-tolerated and safe in the treatment of chronic neuropathic pain, due to a lack of high-quality evidence for their efficacy [143]. Moreover, there is some evidence to support the idea that Cannabis is associated with an increased risk of adverse mental health effects. However, that evidence is generally quite weak as the studies are of low quality, have limited participant numbers, short study durations, a wide variety of cannabinoid preparations and doses, and a frequently, a high rate of bias.

Conclusions in studies into reducing opioid doses in the management of chronic pain, where some trials have shown clinical benefits, are sometimes not completely reliable as they inadequately report dose changes and have mixed results in analgesic effects [144]. Recent analysis has found no evidence to suggest that Cannabis can exert an opioid-sparing effect [145].

Concerning the treatment of inflammatory bowel diseases with cannabinoids, preclinical evidence has indicated that CBD protects against intestinal inflammation (reviewed in [146]). However, GW Pharmaceuticals, who completed a phase IIa pilot study in 2014 did not list CBD for the treatment of ulcerative colitis on its development pipeline [147]. Only products from Vitality Biopharma (cannabinoid prodrugs) seem to be designed for a targeted approach to the gut. Nevertheless, there is global demand for larger clinical trials to be conducted to reveal whether treatment with cannabinoids or their derivatives can provide benefits to inflammatory bowel disease patients.

The impact of cannabinoids on patient-reported outcomes, such as health-related quality of life, has recently been analysed by Goldenberg in a systematic review [148]. Once again, results were disappointing, although there were some small improvements in health-related quality of life for some patients with pain, multiple sclerosis and inflammatory bowel disease. However, reduced effects were observed in some patients with HIV, leading the authors to conclude that the evidence for the effects of cannabinoids on health-related quality of life is inconclusive. The information that is currently available in the reports of reliable randomized controlled trials is clearly limited, although there are increasing reports of considerable subjective effects (pain treatment).

Other systematic reviews have also described harm caused and some commonly reported adverse effects. Cannabis seems to be associated with harm to the central nervous system and the gastro-intestinal system [142,149].

It would therefore appear that the clinical evidence collated to date is confounded by a number of factors, including studies with mixed patient populations, use of different cannabinoid preparations and in various formulations, and wide dosing ranges.

Cannabis-derivative-based medicines may be able to enrich the drug treatment arsenal for chronic pain and inflammation conditions, although this is very much open to debate at the moment. CBD, unlike THC, is not considered an abused drug and several industries are involved in the production of CBD as an active pharmaceutical ingredient with the highest quality standard. It is relevant, and expected, that regulatory agencies, other than the Medications Health Care Products Regulation Agency, will evaluate and approve CBD as a medicine after a careful study of quality, safety and efficacy data [13]. While medicinal cannabis has already entered mainstream medicine in many countries, particular care should be taken in a period in which the on-line availability of a variety of CBD-based products for therapeutic purposes, such as oils, tinctures and vapours, has rapidly expanded and, along with it, an increase in potential health risks for patients/consumers may be expected.

5. Concluding Remarks

Cannabinoids and endocannabinoids are a hot topic in the fields of chemical and biomedical research with more than 1000 articles being published per year and the trend is for that to increase. Furthermore, research into cannabinoid delivery systems is growing and a plethora of patents have shown interest in the companies working in this field, especially when it comes to local/transdermal administration. Combining formulations may provide an opportunity to produce rapid systemic effects and long-term outcomes (e.g., analgesia). This could be achieved with intranasal cannabinoid sprays used as a low-dose adjuvant to patches in order to aid rapid absorption for systemic effects. Interesting and promising transdermal administration results can also be found in the use of terpenes (from the same source) as CBD and THC penetration enhancers, and thus improve the effectiveness of the therapeutic components. This, once again, highlights the role that quality plays in defining the composition, dosage and related safety of the components extracted from cannabis.

It is expected that recent developments in pharmacological, pharmaceutical and technological sciences will result in new therapeutic strategies using both known cannabinoids for new therapeutic strategies as well as cannabinoid synthetic derivatives.

Nanotechnology is indeed a promising approach that may bring cannabinoids closer to clinical use (the SEDDS approach is a fine example), and administration via both the oral and pulmonary routes. Furthermore, it is at an early stage the use of well-known advanced nanomaterials in cannabinoid delivery (e.g., carbon nanotubes). Nevertheless, additional evaluation is required if the cost effectiveness and long-term safety of nano-delivery systems is to be improved.


The authors are grateful to Franca Viola for fruitful discussions. Dale James Matthew Lawson is gratefully thanked for correcting English of the manuscript.